By Madelein Kleyn
Research and development is costly. International patent
portfolios even more so. The business strategy of
most corporations, when filing a patent application, is to
seek some return on R&D investment, mostly through
self-exploitation of the products of R&D, or through royalty
earnings from intellectual Property (IP).
Full articles are available only to LESI Members. Please login to view the PDF of this Les Nouvelles Article.
Not an LESI member? Find out how to join your regional LES society and gain access to all that your LES society and LESI has to offer.